Jupiter Neurosciences draws $1.86M second tranche from Yorkville SEPA; stockholder approval obtained

JUPITER NEUROSCIENCES, INC.

Second Pre-Paid Advance closing on Dec 23, 2025: $1,860,000 disbursed to Jupiter Neurosciences.
Issuance of convertible promissory note to Yorkville in exchange for the funds.
Stockholders approved issuance of shares exceeding 19.99% at annual meeting on Dec 19, 2025.
Registration statement on Form S-1 declared effective Dec 11, enabling resale of shares under SEPA.
Company retains right to direct Yorkville to purchase additional shares up to 100% of 5-day average daily trading volume.

item 1.01 item 2.03 item 3.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.7

JUPITER NEUROSCIENCES, INC. entered into SEPA with Yorkville.

Action: entry
Agreement: equity purchase
Counterparty: Yorkville

Exact text from the filing

he SEPA, Yorkville represented to the Company, among other things, that it is an “accredited investor” (as such term is defined in Rule 501(a) of Regulation D under the Securities Act).

View on SEC.gov

38 material agreements filed in the last 30 days. Browse all material agreements →

JUPITER NEUROSCIENCES, INC. filing history →

Source: SEC EDGAR

accession 0001493152-25-029124

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.